M&A prey Omega snared by Perrigo for $4.5bn
This article was originally published in Scrip
Executive Summary
Irish firm Perrigo has agreed to acquire large over-the-counter healthcare company Omega Pharma for €3.6bn ($4.5bn) – creating a "top-five" global consumer health company.